Biotech

All Articles

Aligos trumpets stage 2 MASH gain, reducing liver body fat around 46%

.Aligos Rehabs is actually proclaiming a midstage succeed in metabolic-dysfunction linked steatohepa...

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work establishing brand new antifungals has actually acquired a significant...

Capricor sells Europe rights to late-stage DMD therapy for $35M

.Possessing already scooped up the united state rights to Capricor Therapies' late-stage Duchenne mu...

FDA junks adcomm for Applied's rare illness medication

.After dismissing the decision date for Applied Therapeutics' metabolic problem drug govorestat, the...

Novo inks $600M NanoVation deal to study hereditary medicines ex-liver

.Novo Nordisk is actually proceeding its own push right into hereditary medications, agreeing to com...

Innovent hyperlinks cytokine to intestines cancer cells feedbacks

.Innovent Biologics has actually created the case that its gate inhibitor-cytokine fusion protein ha...

Merck, Daiichi ADC hits objective in period 3 lung cancer study

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina strengthens AI concentrate along with collab to choose cancer aim ats

.5 months after Rakovina Therapeutics rotated towards expert system, the cancer-focused biotech has ...

Ascendis' dwarfism medication hits in phase 3, intimidates BioMarin

.Ascendis Pharma has become a possible danger to BioMarin's Voxzogo, mentioning stage 3 development ...

Despite ph. 3 miss out on, Alkeus views road ahead of time for eye disease resource

.Though Alkeus Pharmaceuticals' dental eye health condition property fell short to considerably redu...